Stay updated on Atogepant 60mg for Episodic Migraine: Safety Clinical Trial
Sign up to get notified when there's something new on the Atogepant 60mg for Episodic Migraine: Safety Clinical Trial page.

Latest updates to the Atogepant 60mg for Episodic Migraine: Safety Clinical Trial page
- Check3 days agoChange DetectedThe record history now shows Revision: v3.6.2, indicating a recent site version update that changes the footer revision label from the previous v3.6.0.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe record history shows that enrollment has ended for this study, with the recruitment status updated accordingly. A new revision tag v3.6.0 was added and the previous revision v3.5.5 was removed from the history.SummaryDifference0.4%

- Check24 days agoChange DetectedA new revision entry 'Revision: v3.5.5' was added to the history. The 'Revision: v3.5.4' entry and its References were removed, reflecting administrative updates to the page's revision history.SummaryDifference0.3%

- Check38 days agoChange DetectedA References section was added to the study record history page to host source materials and citations related to the record. This addition helps users review the sources supporting the record's updates and data.SummaryDifference0.2%

- Check46 days agoChange DetectedA new revision label 'Revision: v3.5.4' was added to the page history and the previous label 'Revision: v3.5.3' was removed, updating the documented revision history. This reflects a minor update to the record's versioning without altering study data or content.SummaryDifference0.1%

- Check52 days agoChange DetectedThe 'References' row was removed from the Changes list in the version history, so this item will no longer appear among the documented changes for that version.SummaryDifference0.2%

Stay in the know with updates to Atogepant 60mg for Episodic Migraine: Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atogepant 60mg for Episodic Migraine: Safety Clinical Trial page.